Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy.

Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy.

Item
http://www.wikidata.org/entity/Q33606111
Immunotherapy for head and neck cancer: latest developments and clinical potentialAttenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy.Mechanistic insights into ADXS11-001 human papillomavirus-associated cancer immunotherapy.Immunogenicity and efficacy of the novel cancer vaccine based on simian adenovirus and MVA vectors alone and in combination with PD-1 mAb in a mouse model of prostate cancer.Listeria monocytogenes: a promising vehicle for neonatal vaccination.A novel dendritic cell targeting HPV16 E7 synthetic vaccine in combination with PD-L1 blockade elicits therapeutic antitumor immunity in mice.Programmed death-1 & its ligands: promising targets for cancer immunotherapy.Prospects and progress of Listeria-based cancer vaccines.The importance of correctly timing cancer immunotherapy.Recent advances in preclinical model systems for papillomaviruses.A combination of anti-PD-L1 mAb plus Lm-LLO-E6 vaccine efficiently suppresses tumor growth and metastasis in HPV-infected cancers.Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy.Blockade of PD-1 effectively inhibits in vivo malignant transformation of oral mucosa.Therapeutic cancer vaccines.Listeria Monocytogenes: A Model Pathogen Continues to Refine Our Knowledge of the CD8 T Cell Response.as a Vector for Cancer Immunotherapy: Current Understanding and Progress
P2860

Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy.

Item
http://www.wikidata.org/entity/Q33606111
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Anti-PD-1 antibody significant ...... ogenes (Lm)-LLO immunotherapy.
@ast
Anti-PD-1 antibody significant ...... ogenes (Lm)-LLO immunotherapy.
@en
type
label
Anti-PD-1 antibody significant ...... ogenes (Lm)-LLO immunotherapy.
@ast
Anti-PD-1 antibody significant ...... ogenes (Lm)-LLO immunotherapy.
@en
prefLabel
Anti-PD-1 antibody significant ...... ogenes (Lm)-LLO immunotherapy.
@ast
Anti-PD-1 antibody significant ...... ogenes (Lm)-LLO immunotherapy.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Anti-PD-1 antibody significant ...... ogenes (Lm)-LLO immunotherapy.
@en
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P921
P932